(Q43334087)

19 November 2017

title

Effects of granisetron and its combination with dexamethasone on cisplatin-induced delayed emesis in the ferret (English)

1 reference

19 November 2017

1 reference

0 references

Fukunaka N

1 reference

19 November 2017

Sagae S

1 reference

19 November 2017

Kudo R

1 reference

19 November 2017

Endo T

1 reference

19 November 2017

Hirafuji M

1 reference

19 November 2017

Minami M

1 reference

19 November 2017

publication date

1 November 1998

1 reference

19 November 2017

1 reference

19 November 2017

1 reference

19 November 2017

1 reference

19 November 2017

page(s)

775-781

1 reference

The abdominal visceral innervation and the emetic reflex: pathways, pharmacology, and plasticity

19 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2898%2900102-5

7 January 2021

Physiology of nausea and vomiting

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2898%2900102-5

7 January 2021

The anti-emetic potential of the 5-hydroxytryptamine3 receptor antagonist BRL 43694.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2898%2900102-5

7 January 2021

A randomised trial of dexamethasone, lorazepam and prochlorperazine for emesis in patients receiving chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2898%2900102-5

7 January 2021

Endotoxin-stimulated opioid peptide secretion: two secretory pools and feedback control in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2898%2900102-5

7 January 2021

Adrenal corticosteroids as antiemetics during cancer chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2898%2900102-5

7 January 2021

Methylprednisolone enhances the efficacy of ondansetron in acute and delayed cisplatin-induced emesis over at least three cycles. Ondansetron Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2898%2900102-5

7 January 2021

Prophylaxis of delayed nausea and vomiting after cancer chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2898%2900102-5

7 January 2021

Nausea in cancer chemotherapy is inversely related to urinary cortisol excretion

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2898%2900102-5

7 January 2021

Delayed emesis following high-dose cisplatin: a double-blind randomised comparative trial of ondansetron (GR 38032F) versus placebo

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2898%2900102-5

7 January 2021

Control of chemotherapy-induced emesis

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2898%2900102-5

7 January 2021

Dexamethasone can potentiate the anti-emetic action of a 5HT3 receptor antagonist on cyclophosphamide induced vomiting in the ferret

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2898%2900102-5

7 January 2021

5-HT3 receptor antagonists injected into the area postrema inhibit cisplatin-induced emesis in the ferret

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2898%2900102-5

7 January 2021

Endogenous cortisol exerts antiemetic effect similar to that of exogenous corticosteroids

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2898%2900102-5

7 January 2021

In vitro release and tissue levels of ileal serotonin after cisplatin-induced emesis in the cat

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2898%2900102-5

7 January 2021

Regulation of serotonin release from the intestinal mucosa

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2898%2900102-5

7 January 2021

Role of ondansetron plus dexamethasone in fractionated chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2898%2900102-5

7 January 2021

Ondansetron plus dexamethasone compared to the 'standard' metoclopramide combination

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2898%2900102-5

7 January 2021

Platinum Compounds: a New Class of Potent Antitumour Agents

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2898%2900102-5

7 January 2021

The interaction of dexamethasone with ondansetron on drug-induced emesis in the ferret

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2898%2900102-5

7 January 2021

Profiles of emetic action of cisplatin in the ferret: a potential model of acute and delayed emesis

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2898%2900102-5

7 January 2021

Effects of 5-HT3 receptor antagonists on models of acute and delayed emesis induced by cisplatin in the ferret.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2898%2900102-5

7 January 2021

An interaction of ondansetron and dexamethasone antagonizing cisplatin-induced acute and delayed emesis in the ferret

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2898%2900102-5

7 January 2021

Ondansetron compared with granisetron in the prophylaxis of cisplatin-induced acute emesis: a multicentre double-blind, randomised, parallel-group study. The Ondansetron and Granisetron Emesis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2898%2900102-5

7 January 2021

5-Hydroxytryptamine and functional bowel disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2898%2900102-5

7 January 2021

Comparison of ondansetron and ondansetron plus dexamethasone as antiemetic prophylaxis during cisplatin-containing chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2898%2900102-5

7 January 2021

Antiemetic properties of the 5HT3-receptor antagonist, GR38032F

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2898%2900102-5

7 January 2021

Some statistical methods useful in circulation research.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2898%2900102-5

7 January 2021

The nephrotoxic effects of cis-diammine-dichloroplatinum (II) (NSC-119875) in male F344 rats

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2898%2900102-5

7 January 2021

Urinary serotonin metabolite excretion during cisplatin chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2898%2900102-5

7 January 2021

10.1016/S0306-3623(98)00102-5

Identifiers

DOI

1 reference

19 November 2017

1 reference